<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01510821</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00049331</org_study_id>
    <nct_id>NCT01510821</nct_id>
  </id_info>
  <brief_title>Investigation of Endothelium in Saphenous Vein Grafts</brief_title>
  <official_title>A Prospective Trial to Investigate Endothelial Dysfunction in Saphenous Vein Grafts Subjected to the Maquet Vasoshield Pressure Limiting Syringe Versus Non-Regulated Vessel Dilation in Patients Undergoing Coronary Artery Bypass Grafting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Maquet Cardiovascular</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single center prospective study of 30 patients undergoing elective heart bypass
      surgery (CABG) with at least two vein grafts from the leg (SVG). The purpose of this ex vivo
      study is to evaluate the function of vein grafts from small tissue samples treated with a
      pressure syringe and a non-pressure syringe. Syringes are routinely used to flush out the
      veins in preparation of bypass grafting. It is unknown if different levels of pressure in the
      syringe affect the vein or damage the vein. Small sections of tissue samples which are
      normally discarded will be obtained immediately after retrieval from the leg and before
      grafting to the heart. Tissue samples will be taken to the laboratory for study. There are no
      clinical endpoints in this study, however, clinical information will be obtained from the
      Society of Thoracic Surgeons database and will include demographics, risk factors, and
      perioperative outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SVG vascular contractility</measure>
    <time_frame>Day of surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nitric oxide metabolite levels</measure>
    <time_frame>Day of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>6 months and 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Endothelial Function of Saphenous Vein Grafts</condition>
  <arm_group>
    <arm_group_label>Maquet Vasoshield Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pressure limiting syringe</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-regulated Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard non-regulated syringe</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Use of Maquet Vasoshield Pressure-limiting syringe on SVG</intervention_name>
    <description>Use of Maquet Vasoshield Pressure-limiting syringe on SVG</description>
    <arm_group_label>Maquet Vasoshield Arm</arm_group_label>
    <other_name>Maquet device</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Use of non-regulated syringe on SVG</intervention_name>
    <description>Use of non-regulated syringe on SVG</description>
    <arm_group_label>Non-regulated Arm</arm_group_label>
    <other_name>standard syringe</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing elective coronary artery bypass graft surgery requiring at least 2
             saphenous vein grafts

        Exclusion Criteria:

          -  patients undergoing any concomitant surgical procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vinod Thourani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiothoracic Surgery Research Laboratory</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital Midtown</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 2, 2011</study_first_submitted>
  <study_first_submitted_qc>January 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2012</study_first_posted>
  <last_update_submitted>September 30, 2013</last_update_submitted>
  <last_update_submitted_qc>September 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Vinod Thourani</investigator_full_name>
    <investigator_title>Associate Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>endoscopic vein harvest</keyword>
  <keyword>saphenous vein graft</keyword>
  <keyword>endothelial function</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

